Compare Stocks

4 / 10
Try these comparisons:

Stock Comparison

STSS vs NNBR vs SMPL vs MMSI

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
STSS
Sharps Technology, Inc.

Medical - Instruments & Supplies

HealthcareNASDAQ • US
Market Cap$8K
5Y Perf.-100.0%
NNBR
NN, Inc.

Conglomerates

IndustrialsNASDAQ • US
Market Cap$139M
5Y Perf.-8.9%
SMPL
The Simply Good Foods Company

Packaged Foods

Consumer DefensiveNASDAQ • US
Market Cap$1.24B
5Y Perf.-70.1%
MMSI
Merit Medical Systems, Inc.

Medical - Instruments & Supplies

HealthcareNASDAQ • US
Market Cap$3.72B
5Y Perf.+0.5%

STSS vs NNBR vs SMPL vs MMSI — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
STSS logoSTSS
NNBR logoNNBR
SMPL logoSMPL
MMSI logoMMSI
IndustryMedical - Instruments & SuppliesConglomeratesPackaged FoodsMedical - Instruments & Supplies
Market Cap$8K$139M$1.24B$3.72B
Revenue (TTM)$223K$435M$1.45B$1.54B
Net Income (TTM)$-723K$-35M$91M$139M
Gross Margin-7.6%2.3%34.0%48.7%
Operating Margin-40.9%-3.3%14.4%12.2%
Forward P/E43.6x7.5x15.5x
Total Debt$4M$211M$304M$898M
Cash & Equiv.$864K$11M$98M$449M

STSS vs NNBR vs SMPL vs MMSILong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

STSS
NNBR
SMPL
MMSI
StockApr 22May 26Return
Sharps Technology, … (STSS)1000.0-100.0%
NN, Inc. (NNBR)10091.1-8.9%
The Simply Good Foo… (SMPL)10029.9-70.1%
Merit Medical Syste… (MMSI)100100.5+0.5%

Price return only. Dividends and distributions are not included.

Quick Verdict: STSS vs NNBR vs SMPL vs MMSI

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: SMPL and MMSI are tied at the top with 2 categories each — the right choice depends on your priorities. Merit Medical Systems, Inc. is the stronger pick specifically for profitability and margin quality and operational efficiency and capital deployment. STSS and NNBR also each lead in at least one category. This set spans 3 sectors — these stocks serve different portfolio roles, not just different price points.
STSS
Sharps Technology, Inc.
The Growth Leader

STSS is the clearest fit if your priority is growth.

  • 99.1% revenue growth vs NNBR's -9.1%
Best for: growth
NNBR
NN, Inc.
The Momentum Pick

NNBR is the clearest fit if your priority is momentum.

  • +50.8% vs SMPL's -64.8%
Best for: momentum
SMPL
The Simply Good Foods Company
The Income Pick

SMPL has the current edge in this matchup, primarily because of its strength in income & stability and sleep-well-at-night.

  • beta 0.38
  • Lower volatility, beta 0.38, Low D/E 16.8%, current ratio 3.64x
  • Beta 0.38, current ratio 3.64x
  • Lower P/E (7.5x vs 15.5x)
Best for: income & stability and sleep-well-at-night
MMSI
Merit Medical Systems, Inc.
The Growth Play

MMSI is the #2 pick in this set and the best alternative if growth exposure and long-term compounding is your priority.

  • Rev growth 11.7%, EPS growth 4.9%, 3Y rev CAGR 9.6%
  • 214.6% 10Y total return vs SMPL's 3.7%
  • 9.0% margin vs STSS's -324.8%
  • 5.2% ROA vs NNBR's -7.7%, ROIC 7.2% vs -4.5%
Best for: growth exposure and long-term compounding
See the full category breakdown
CategoryWinnerWhy
GrowthSTSS logoSTSS99.1% revenue growth vs NNBR's -9.1%
ValueSMPL logoSMPLLower P/E (7.5x vs 15.5x)
Quality / MarginsMMSI logoMMSI9.0% margin vs STSS's -324.8%
Stability / SafetySMPL logoSMPLBeta 0.38 vs STSS's 2.56, lower leverage
DividendsTieNone of these 4 stocks pay a meaningful dividend
Momentum (1Y)NNBR logoNNBR+50.8% vs SMPL's -64.8%
Efficiency (ROA)MMSI logoMMSI5.2% ROA vs NNBR's -7.7%, ROIC 7.2% vs -4.5%

STSS vs NNBR vs SMPL vs MMSI — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

STSSSharps Technology, Inc.

Segment breakdown not available.

NNBRNN, Inc.
FY 2025
Automotive
58.5%$247M
Electrical
17.7%$75M
General Industrial
12.8%$54M
Other End Market
11.0%$46M
SMPLThe Simply Good Foods Company
FY 2025
Shipping and Handling
100.0%$103M
MMSIMerit Medical Systems, Inc.
FY 2025
Cardiovascular
95.2%$1.4B
Endoscopy
4.8%$73M

STSS vs NNBR vs SMPL vs MMSI — Financial Metrics

Side-by-side numbers across 4 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLMMSILAGGINGSTSS

Income & Cash Flow (Last 12 Months)

MMSI leads this category, winning 3 of 6 comparable metrics.

MMSI is the larger business by revenue, generating $1.5B annually — 6924.7x STSS's $222,722. MMSI is the more profitable business, keeping 9.0% of every revenue dollar as net income compared to STSS's -3.2%. On growth, NNBR holds the edge at +12.1% YoY revenue growth, suggesting stronger near-term business momentum.

MetricSTSS logoSTSSSharps Technology…NNBR logoNNBRNN, Inc.SMPL logoSMPLThe Simply Good F…MMSI logoMMSIMerit Medical Sys…
RevenueTrailing 12 months$222,722$435M$1.4B$1.5B
EBITDAEarnings before interest/tax-$8M$22M$231M$290M
Net IncomeAfter-tax profit-$723,347-$35M$91M$139M
Free Cash FlowCash after capex-$10M-$1M$174M$274M
Gross MarginGross profit ÷ Revenue-7.6%+2.3%+34.0%+48.7%
Operating MarginEBIT ÷ Revenue-40.9%-3.3%+14.4%+12.2%
Net MarginNet income ÷ Revenue-3.2%-8.0%+6.3%+9.0%
FCF MarginFCF ÷ Revenue-44.2%-0.3%+12.0%+17.8%
Rev. Growth (YoY)Latest quarter vs prior year+12.1%-0.3%+7.8%
EPS Growth (YoY)Latest quarter vs prior year+111.0%-8.7%-31.6%+38.8%
MMSI leads this category, winning 3 of 6 comparable metrics.

Valuation Metrics

SMPL leads this category, winning 3 of 6 comparable metrics.

At 12.2x trailing earnings, SMPL trades at a 58% valuation discount to MMSI's 29.3x P/E. On an enterprise value basis, SMPL's 6.0x EV/EBITDA is more attractive than NNBR's 19.0x.

MetricSTSS logoSTSSSharps Technology…NNBR logoNNBRNN, Inc.SMPL logoSMPLThe Simply Good F…MMSI logoMMSIMerit Medical Sys…
Market CapShares × price$7,830$139M$1.2B$3.7B
Enterprise ValueMkt cap + debt − cash$3M$338M$1.4B$4.2B
Trailing P/EPrice ÷ TTM EPS-0.00x-2.58x12.20x29.26x
Forward P/EPrice ÷ next-FY EPS est.43.60x7.45x15.46x
PEG RatioP/E ÷ EPS growth rate0.51x
EV / EBITDAEnterprise value multiple19.03x5.97x13.06x
Price / SalesMarket cap ÷ Revenue0.33x0.86x2.45x
Price / BookPrice ÷ Book value/share0.00x0.93x0.70x2.38x
Price / FCFMarket cap ÷ FCF19.16x7.86x17.24x
SMPL leads this category, winning 3 of 6 comparable metrics.

Profitability & Efficiency

MMSI leads this category, winning 4 of 9 comparable metrics.

MMSI delivers a 8.9% return on equity — every $100 of shareholder capital generates $9 in annual profit, vs $-28 for NNBR. SMPL carries lower financial leverage with a 0.17x debt-to-equity ratio, signaling a more conservative balance sheet compared to STSS's 1.89x. On the Piotroski fundamental quality scale (0–9), MMSI scores 6/9 vs NNBR's 3/9, reflecting solid financial health.

MetricSTSS logoSTSSSharps Technology…NNBR logoNNBRNN, Inc.SMPL logoSMPLThe Simply Good F…MMSI logoMMSIMerit Medical Sys…
ROE (TTM)Return on equity-5.0%-28.4%+5.2%+8.9%
ROA (TTM)Return on assets-4.2%-7.7%+3.7%+5.2%
ROICReturn on invested capital-120.0%-4.5%+8.1%+7.2%
ROCEReturn on capital employed-153.7%-5.0%+9.4%+7.9%
Piotroski ScoreFundamental quality 0–93356
Debt / EquityFinancial leverage1.89x1.44x0.17x0.57x
Net DebtTotal debt minus cash$3M$200M$206M$450M
Cash & Equiv.Liquid assets$864,041$11M$98M$449M
Total DebtShort + long-term debt$4M$211M$304M$898M
Interest CoverageEBIT ÷ Interest expense-0.20x-0.74x6.77x10.74x
MMSI leads this category, winning 4 of 9 comparable metrics.

Total Returns (Dividends Reinvested)

NNBR leads this category, winning 4 of 6 comparable metrics.

A $10,000 investment in MMSI five years ago would be worth $9,644 today (with dividends reinvested), compared to $1 for STSS. Over the past 12 months, NNBR leads with a +50.8% total return vs SMPL's -64.8%. The 3-year compound annual growth rate (CAGR) favors NNBR at 40.7% vs STSS's -92.9% — a key indicator of consistent wealth creation.

MetricSTSS logoSTSSSharps Technology…NNBR logoNNBRNN, Inc.SMPL logoSMPLThe Simply Good F…MMSI logoMMSIMerit Medical Sys…
YTD ReturnYear-to-date-16.5%+106.0%-36.4%-27.9%
1-Year ReturnPast 12 months-59.9%+50.8%-64.8%-33.8%
3-Year ReturnCumulative with dividends-100.0%+178.4%-67.8%-26.5%
5-Year ReturnCumulative with dividends-100.0%-63.4%-64.3%-3.6%
10-Year ReturnCumulative with dividends-100.0%-75.7%+3.7%+214.6%
CAGR (3Y)Annualised 3-year return-92.9%+40.7%-31.5%-9.8%
NNBR leads this category, winning 4 of 6 comparable metrics.

Risk & Volatility

Evenly matched — NNBR and SMPL each lead in 1 of 2 comparable metrics.

SMPL is the less volatile stock with a 0.38 beta — it tends to amplify market swings less than STSS's 2.56 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. NNBR currently trades 92.3% from its 52-week high vs STSS's 10.3% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricSTSS logoSTSSSharps Technology…NNBR logoNNBRNN, Inc.SMPL logoSMPLThe Simply Good F…MMSI logoMMSIMerit Medical Sys…
Beta (5Y)Sensitivity to S&P 5002.56x2.04x0.38x0.71x
52-Week HighHighest price in past year$18.23$2.99$36.92$100.19
52-Week LowLowest price in past year$1.42$1.10$10.21$59.74
% of 52W HighCurrent price vs 52-week peak+10.3%+92.3%+33.7%+62.2%
RSI (14)Momentum oscillator 0–10055.665.642.934.9
Avg Volume (50D)Average daily shares traded327K936K2.8M769K
Evenly matched — NNBR and SMPL each lead in 1 of 2 comparable metrics.

Analyst Outlook

Insufficient data to determine a leader in this category.

Analyst consensus: NNBR as "Buy", SMPL as "Buy", MMSI as "Buy". Consensus price targets imply 62.1% upside for SMPL (target: $20) vs 52.4% for MMSI (target: $95).

MetricSTSS logoSTSSSharps Technology…NNBR logoNNBRNN, Inc.SMPL logoSMPLThe Simply Good F…MMSI logoMMSIMerit Medical Sys…
Analyst RatingConsensus buy/hold/sellBuyBuyBuy
Price TargetConsensus 12-month target$20.17$95.00
# AnalystsCovering analysts92413
Dividend YieldAnnual dividend ÷ price
Dividend StreakConsecutive years of raises0
Dividend / ShareAnnual DPS
Buyback YieldShare repurchases ÷ mkt cap0.0%0.0%+4.1%0.0%
Insufficient data to determine a leader in this category.
Key Takeaway

MMSI leads in 2 of 6 categories (Income & Cash Flow, Profitability & Efficiency). SMPL leads in 1 (Valuation Metrics). 1 tied.

Best OverallMerit Medical Systems, Inc. (MMSI)Leads 2 of 6 categories
Loading custom metrics...

STSS vs NNBR vs SMPL vs MMSI: Key Questions Answered

10 questions · data-driven answers · updated daily

01

Is STSS or NNBR or SMPL or MMSI a better buy right now?

For growth investors, Merit Medical Systems, Inc.

(MMSI) is the stronger pick with 11. 7% revenue growth year-over-year, versus -9. 1% for NN, Inc. (NNBR). The Simply Good Foods Company (SMPL) offers the better valuation at 12. 2x trailing P/E (7. 5x forward), making it the more compelling value choice. Analysts rate NN, Inc. (NNBR) a "Buy" — based on 9 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which has the better valuation — STSS or NNBR or SMPL or MMSI?

On trailing P/E, The Simply Good Foods Company (SMPL) is the cheapest at 12.

2x versus Merit Medical Systems, Inc. at 29. 3x. On forward P/E, The Simply Good Foods Company is actually cheaper at 7. 5x.

03

Which is the better long-term investment — STSS or NNBR or SMPL or MMSI?

Over the past 5 years, Merit Medical Systems, Inc.

(MMSI) delivered a total return of -3. 6%, compared to -100. 0% for Sharps Technology, Inc. (STSS). Over 10 years, the gap is even starker: MMSI returned +214. 6% versus STSS's -100. 0%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

04

Which is safer — STSS or NNBR or SMPL or MMSI?

By beta (market sensitivity over 5 years), The Simply Good Foods Company (SMPL) is the lower-risk stock at 0.

38β versus Sharps Technology, Inc. 's 2. 56β — meaning STSS is approximately 575% more volatile than SMPL relative to the S&P 500. On balance sheet safety, The Simply Good Foods Company (SMPL) carries a lower debt/equity ratio of 17% versus 189% for Sharps Technology, Inc. — giving it more financial flexibility in a downturn.

05

Which is growing faster — STSS or NNBR or SMPL or MMSI?

By revenue growth (latest reported year), Merit Medical Systems, Inc.

(MMSI) is pulling ahead at 11. 7% versus -9. 1% for NN, Inc. (NNBR). On earnings-per-share growth, the picture is similar: Merit Medical Systems, Inc. grew EPS 4. 9% year-over-year, compared to -782. 0% for Sharps Technology, Inc.. Over a 3-year CAGR, MMSI leads at 9. 6% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

06

Which has better profit margins — STSS or NNBR or SMPL or MMSI?

Merit Medical Systems, Inc.

(MMSI) is the more profitable company, earning 8. 5% net margin versus -324. 8% for Sharps Technology, Inc. — meaning it keeps 8. 5% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: SMPL leads at 15. 1% versus -40. 9% for STSS. At the gross margin level — before operating expenses — MMSI leads at 48. 7%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

07

Is STSS or NNBR or SMPL or MMSI more undervalued right now?

On forward earnings alone, The Simply Good Foods Company (SMPL) trades at 7.

5x forward P/E versus 43. 6x for NN, Inc. — 36. 1x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for SMPL: 62. 1% to $20. 17.

08

Which pays a better dividend — STSS or NNBR or SMPL or MMSI?

None of the stocks in this comparison currently pay a material dividend.

All are effectively zero-yield and should be held for capital appreciation rather than income.

09

Is STSS or NNBR or SMPL or MMSI better for a retirement portfolio?

For long-horizon retirement investors, The Simply Good Foods Company (SMPL) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.

38)). Sharps Technology, Inc. (STSS) carries a higher beta of 2. 56 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (SMPL: +3. 7%, STSS: -100. 0%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

10

What are the main differences between STSS and NNBR and SMPL and MMSI?

These companies operate in different sectors (STSS (Healthcare) and NNBR (Industrials) and SMPL (Consumer Defensive) and MMSI (Healthcare)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: STSS is a small-cap quality compounder stock; NNBR is a small-cap quality compounder stock; SMPL is a small-cap deep-value stock; MMSI is a small-cap quality compounder stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.

Stocks Like

STSS

Quality Business

  • Sector: Healthcare
  • Market Cap > $500M
Run This Screen
Stocks Like

NNBR

Quality Business

  • Sector: Industrials
  • Market Cap > $100B
  • Revenue Growth > 6%
Run This Screen
Stocks Like

SMPL

Quality Business

  • Sector: Consumer Defensive
  • Market Cap > $100B
  • Net Margin > 5%
Run This Screen
Stocks Like

MMSI

Quality Business

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 5%
  • Net Margin > 5%
Run This Screen

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.